1. Sex effects in predictors of smoking abstinence and neuropsychiatric adverse events in the EAGLES trial
- Author
-
McKee, Sherry A, Lawrence, David E, Saccone, Phillip, McRae, Thomas, and Anthenelli, Robert M
- Subjects
Biomedical and Clinical Sciences ,Biological Psychology ,Health Sciences ,Psychology ,Pharmacology and Pharmaceutical Sciences ,Clinical Research ,Minority Health ,Behavioral and Social Science ,Tobacco ,Women's Health ,Brain Disorders ,Tobacco Smoke and Health ,Mental Health ,Substance Misuse ,Prevention ,6.1 Pharmaceuticals ,Respiratory ,Cardiovascular ,Mental health ,Good Health and Well Being ,Sex ,Smoking cessation medication ,Cessation ,Neuropsychiatric adverse events - Abstract
Significance There are sex effects in abstinence outcomes across all smoking cessation medications, but there is limited information regarding sex effects on cessation-related neuropsychiatric adverse events (NPSAEs) or interactions with psychiatric status.MethodsSecondary analysis of data from EAGLES of 8144 adults who smoke cigarettes randomized to varenicline, bupropion, nicotine patch or placebo. Design characteristics included region (within/outside US), psychiatric cohort (absent/present), and treatment. Baseline variables included demographics, smoking history, prior use of study treatments, lifetime suicide-related history, and prior psychiatric co-morbidities and medication use. Design characteristics were forced into logistic regressions models, and then interactions among sex, design elements, and baseline characteristics were evaluated for NPSAEs and 6-month cessation outcomes.ResultsFindings demonstrated a significant interaction of sex and race (p
- Published
- 2023